In response to the COVID-19 pandemic, there are over 500 global clinical trials taking place to develop life-saving treatments and vaccines for patients. In these unprecedented times, sponsors must utilize innovative tools and approaches to design their clinical trials in order to provide promising results for all patient populations as quickly and efficiently as possible.
Cytel invites you to join drug development and trial design experts for a complimentary virtual panel discussion, which will begin with challenges faced by clinicians and drug developers, followed by examples of tools and trial designs currently being used to help sponsors of COVID-19 trials.
The panelist will discuss:
-Challenges on the front lines of the pandemic for clinicians
-Drug development during a pandemic
-How to operate a Global COVID-19 Clinical Trial Tracker to help facilitate greater collaboration between researchers, policymakers, clinicians, journalists, philanthropists, and other critical stakeholders who need to understand the complex dynamics of the global response to finding a solution to the COVID-19 outbreak
-Innovative trial designs during a pandemic for promising results
Edward Mills, PhD, FRCP Edin
Srinivas Murthy, MD. Critical Care Physician, University of British Columbia & Co-Chair SOLIDARITY trial from WHO
Craig Rayner, PharmD. President, Integrated Drug Development, Certara
Louis Dron, MSc. Senior Analyst, Cytel
Kristian Thorlund, PhD. SVP, Cytel